Omkar Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve Audited Financial results ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Omkar Pharmachem Ltd has informed BSE that its Board of Directors will meet on Thursday, May 29, 2025, at 4:15 PM at the registered office. The key agenda item is to consider and approve the Audited Financial Results for the quarter and financial year ended March 31, 2025. The company also confirmed that the trading window for its shares will remain closed until May 31, 2025 for all designated persons and their immediate relatives. This is a routine regulatory filing under SEBI LODR Regulation 29(1)(a) ahead of the upcoming earnings announcement.
This is a standard advance notice with no direct impact on the stock. Investors should wait for the actual audited results on May 29, 2025 to assess Q4 and full-year performance, earnings quality, and any board decisions on dividends or other corporate actions.